Dermatology · Troy, MI
NPI
1891819801
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
38865 Dequindre Rd, Suite 104
Troy, MI, 48083
Phone (248) 743-9330
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
2,130 services
Medicare patients, 2024
243
Average age 73
Drug cost, 2024
$529K
3,515 prescriptions
Company payments, 2025
$3,747
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farah K Malick was code J3301 (injection, triamcinolone acetonide, not otherwise specified, 10 mg), 521 times for 62 patients. In total Farah K Malick billed 2,130 services in 36 codes, and Medicare paid $71K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-16.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 521 | 62 | $0.68 | $355 |
| 99213 Office E&M - Established | Office | 416 | 187 | $67.53 | $28K |
| 17003 Destruction Skin Lesion | Office | 379 | 68 | $4.78 | $1,811 |
| 96372 Injection Administration | Office | 177 | 62 | $10.24 | $1,813 |
| 17000 Destruction Skin Lesion | Office | 138 | 77 | $39.68 | $5,476 |
| 17110 Destruction Skin Lesion | Office | 99 | 66 | $81.48 | $8,067 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 70 | 28 | $0.89 | $62.6 |
| 99203 Office E&M - New | Office | 63 | 63 | $84.51 | $5,324 |
| 11901 Skin | Office | 46 | 19 | $44.11 | $2,029 |
| 99214 Office E&M - Established | Office | 41 | 34 | $94.97 | $3,894 |
| 11900 Skin | Office | 34 | 20 | $34.82 | $1,184 |
| 10040 Removal or Shaving of Skin Growth | Office | 26 | 15 | $86.53 | $2,250 |
| 11102 Skin Biopsy | Office | 23 | 22 | $63.27 | $1,455 |
| 17004 Destruction Skin Lesion | Office | 20 | 11 | $114.14 | $2,283 |
| 11104 Skin Biopsy | Office | 20 | 19 | $93.84 | $1,877 |
By year: 2023 $25K for 795 services; 2024 $71K for 2,130 services.
Medicare prescription drug claims, 2024
In 2024, the drug Farah K Malick prescribed most often to Medicare patients was Betamethasone Dipropionate, with 466 prescriptions and refills. In total Farah K Malick wrote 3,515 Medicare prescriptions that cost $529K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Betamethasone Dipropionate Generic | 466 | 483 | 169 | $17K |
| Ketoconazole Generic | 280 | 306 | 93 | $4,371 |
| Triamcinolone Acetonide Generic | 248 | 276 | 124 | $4,192 |
| Fluticasone Propionate Generic | 246 | 257 | 107 | $6,291 |
| Selenium Sulfide Generic | 231 | 254 | 73 | $2,827 |
| Ammonium Lactate Generic | 170 | 217 | 73 | $4,078 |
| Clobetasol Propionate Generic | 168 | 193 | 59 | $5,345 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 162 | 174 | 59 | $2,722 |
| Halobetasol Propionate Generic | 115 | 125 | 42 | $7,667 |
| Clindamycin Phosphate Generic | 109 | 116 | 40 | $2,355 |
| Mometasone Furoate Generic | 89 | 92 | 42 | $1,431 |
| Mupirocin Generic | 86 | 93 | 49 | $640 |
| Nystatin Generic | 61 | 65 | 30 | $1,072 |
| Metronidazole Generic | 58 | 66 | 17 | $3,401 |
| Westab Plus Pnv,calcium 72/Iron/Folic Acid | 57 | 69 | Under 11 | $535 |
Brand drugs: 163 claims; generic drugs: 3,230 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farah K Malick $3,747 ($3,747 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $506.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 5 | $506 |
| Janssen Biotech, Inc. JNJ | 4 | $471 |
| LEO Pharma Inc. | 4 | $453 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 5 | $432 |
| UCB, Inc. UCB.BR | 3 | $359 |
| Galderma Laboratories, L.P. GALD.SW | 7 | $277 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $256 |
| Amgen Inc. AMGN | 4 | $160 |
| Arcutis Biotherapeutics, Inc. ARQT | 3 | $156 |
| Genzyme Corporation SNY | 1 | $126 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.